BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 17335878)

  • 1. Nuclear inositide signaling: an appraisal of phospholipase C beta 1 behavior in myelodysplastic and leukemia cells.
    Cocco L; Follo MY; Faenza I; Bavelloni A; Billi AM; Martelli AM; Manzoli L
    Adv Enzyme Regul; 2007; 47():2-9. PubMed ID: 17335878
    [No Abstract]   [Full Text] [Related]  

  • 2. Inositide signaling: Nuclear targets and involvement in myelodysplastic syndromes.
    Cocco L; Faenza I; Follo MY; Ramazzotti G; Gaboardi GC; Billi AM; Martelli AM; Manzoli L
    Adv Enzyme Regul; 2008; 48():2-9. PubMed ID: 18280812
    [No Abstract]   [Full Text] [Related]  

  • 3. Physiology and pathology of nuclear phospholipase C β1.
    Cocco L; Follo MY; Faenza I; Fiume R; Ramazzotti G; Weber G; Martelli AM; Manzoli FA
    Adv Enzyme Regul; 2011; 51(1):2-12. PubMed ID: 21035488
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nuclear inositide signaling in myelodysplastic syndromes.
    Follo MY; Mongiorgi S; Finelli C; Clissa C; Ramazzotti G; Fiume R; Faenza I; Manzoli L; Martelli AM; Cocco L
    J Cell Biochem; 2010 Apr; 109(6):1065-71. PubMed ID: 20058233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear phospholipase C beta1, regulation of the cell cycle and progression of acute myeloid leukemia.
    Cocco L; Manzoli L; Palka G; Martelli AM
    Adv Enzyme Regul; 2005; 45():126-35. PubMed ID: 16024064
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear PI-PLC β1 and Myelodysplastic syndromes: from bench to clinics.
    Mongiorgi S; Follo MY; Clissa C; Giardino R; Fini M; Manzoli L; Ramazzotti G; Fiume R; Finelli C; Cocco L
    Curr Top Microbiol Immunol; 2012; 362():235-45. PubMed ID: 23086421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New frontiers of inositide-specific phospholipase C in nuclear signalling.
    Cocco L; Maraldi NM; Manzoli FA
    Eur J Histochem; 2004; 48(1):83-8. PubMed ID: 15145779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inositide signaling in the nucleus: from physiology to pathology.
    Cocco L; Follo MY; Faenza I; Billi AM; Ramazzotti G; Martelli AM; Manzoli L; Weber G
    Adv Enzyme Regul; 2010; 50(1):2-11. PubMed ID: 19895834
    [No Abstract]   [Full Text] [Related]  

  • 9. Revisiting nuclear phospholipase C signalling in MDS.
    Follo MY; Faenza I; Fiume R; Ramazzotti G; McCubrey JA; Martelli AM; Manzoli FA; Cocco L
    Adv Biol Regul; 2012 Jan; 52(1):2-6. PubMed ID: 21982979
    [No Abstract]   [Full Text] [Related]  

  • 10. Nuclear phospholipase C signaling through type 1 IGF receptor and its involvement in cell growth and differentiation.
    Faenza I; Billi AM; Follo MY; Fiume R; Martelli AM; Cocco L; Manzoli L
    Anticancer Res; 2005; 25(3B):2039-41. PubMed ID: 16158942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nuclear inositides: PI-PLC signaling in cell growth, differentiation and pathology.
    Cocco L; Faenza I; Follo MY; Billi AM; Ramazzotti G; Papa V; Martelli AM; Manzoli L
    Adv Enzyme Regul; 2009; 49(1):2-10. PubMed ID: 19159640
    [No Abstract]   [Full Text] [Related]  

  • 12. Phosphoinositide-specific phospholipase C beta1 signal transduction in the nucleus.
    Fiume R; Teti G; Faenza I; Cocco L
    Methods Mol Biol; 2010; 645():143-64. PubMed ID: 20645187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The physiology and pathology of inositide signaling in the nucleus.
    Ramazzotti G; Faenza I; Fiume R; Matteucci A; Piazzi M; Follo MY; Cocco L
    J Cell Physiol; 2011 Jan; 226(1):14-20. PubMed ID: 20658523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear phosphoinositides: location, regulation and function.
    Fiume R; Keune WJ; Faenza I; Bultsma Y; Ramazzotti G; Jones DR; Martelli AM; Somner L; Follo MY; Divecha N; Cocco L
    Subcell Biochem; 2012; 59():335-61. PubMed ID: 22374096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inositide-specific phospholipase C signalling in the nucleus.
    Cocco L; Rhee SG; Gilmour RS; Manzoli FA
    Eur J Histochem; 2000; 44(1):45-50. PubMed ID: 10868292
    [No Abstract]   [Full Text] [Related]  

  • 16. Nuclear PI-PLCβ1: an appraisal on targets and pathology.
    Follo MY; Faenza I; Piazzi M; Blalock WL; Manzoli L; McCubrey JA; Cocco L
    Adv Biol Regul; 2014 Jan; 54():2-11. PubMed ID: 24296032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significance of nuclear phospholipase C signaling through type 1 IGF receptor.
    Cocco L; Capitani S; Maraldi NM; Martelli AM; Mazzotti G; Manzoli FA
    J Endocrinol Invest; 2004; 27(6 Suppl):143-5. PubMed ID: 15481815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nuclear Inositide Signaling Via Phospholipase C.
    Ratti S; Mongiorgi S; Ramazzotti G; Follo MY; Mariani GA; Suh PG; McCubrey JA; Cocco L; Manzoli L
    J Cell Biochem; 2017 Aug; 118(8):1969-1978. PubMed ID: 28106288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topology of inositol lipid signal transduction in the nucleus.
    Maraldi NM; Zini N; Santi S; Manzoli FA
    J Cell Physiol; 1999 Nov; 181(2):203-17. PubMed ID: 10497300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nuclear Inositides and Inositide-Dependent Signaling Pathways in Myelodysplastic Syndromes.
    Xian J; Owusu Obeng E; Ratti S; Rusciano I; Marvi MV; Fazio A; De Stefano A; Mongiorgi S; Cappellini A; Ramazzotti G; Manzoli L; Cocco L; Follo MY
    Cells; 2020 Mar; 9(3):. PubMed ID: 32178280
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.